Artwork

Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Boyd Swinburn: Auckland University professor on whether or not the Government needs to fund Wegovy

2:46
 
Share
 

Manage episode 491816523 series 2882353
Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts.

It's become available from pharmacies under prescription - from today.

It's not funded by Pharmac, and costs about $500 dollars per month.

Auckland University population nutrition professor, Boyd Swinburn, says that is unaffordable for the public purse.

"When the first generation of these drugs come off patent, their price will drop enormously and that will give Pharmac a chance to really negotiate the price."

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

9805 episodes

Artwork
iconShare
 
Manage episode 491816523 series 2882353
Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts.

It's become available from pharmacies under prescription - from today.

It's not funded by Pharmac, and costs about $500 dollars per month.

Auckland University population nutrition professor, Boyd Swinburn, says that is unaffordable for the public purse.

"When the first generation of these drugs come off patent, their price will drop enormously and that will give Pharmac a chance to really negotiate the price."

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

9805 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play